FR2417105A1 - Composition a base d'uricase et son application au dosage de l'acide urique - Google Patents

Composition a base d'uricase et son application au dosage de l'acide urique

Info

Publication number
FR2417105A1
FR2417105A1 FR7900447A FR7900447A FR2417105A1 FR 2417105 A1 FR2417105 A1 FR 2417105A1 FR 7900447 A FR7900447 A FR 7900447A FR 7900447 A FR7900447 A FR 7900447A FR 2417105 A1 FR2417105 A1 FR 2417105A1
Authority
FR
France
Prior art keywords
uricase
application
uric acid
dosage
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7900447A
Other languages
English (en)
Other versions
FR2417105B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc
Publication of FR2417105A1 publication Critical patent/FR2417105A1/fr
Application granted granted Critical
Publication of FR2417105B1 publication Critical patent/FR2417105B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
    • C12N9/0046—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/62—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving uric acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention a trait au domaine des épreuves diagnostiques. Elle concerne plus particulièrement une composition perfectionnée renfermant une substance douée d'activité d'uricase, au moins un chromogène et une substance douée d'activité de peroxydase,le perfectionnement résidant dans le fait que la substance douée d'activité d'uricase est une uricase d'origine animale qui est exempte d'impuretés sensibles au pH, dont le poids moléculaire est inférieur à environ 6 000. Application au dosage de l'acide urique dans un échantillon liquide.
FR7900447A 1978-02-13 1979-01-09 Composition a base d'uricase et son application au dosage de l'acide urique Granted FR2417105A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/877,500 US4230798A (en) 1978-02-13 1978-02-13 Unitized uric acid test composition and device

Publications (2)

Publication Number Publication Date
FR2417105A1 true FR2417105A1 (fr) 1979-09-07
FR2417105B1 FR2417105B1 (fr) 1983-07-08

Family

ID=25370107

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7900447A Granted FR2417105A1 (fr) 1978-02-13 1979-01-09 Composition a base d'uricase et son application au dosage de l'acide urique

Country Status (8)

Country Link
US (1) US4230798A (fr)
JP (3) JPS584916B2 (fr)
AU (1) AU514609B2 (fr)
CA (1) CA1093440A (fr)
DE (1) DE2855433C2 (fr)
FR (1) FR2417105A1 (fr)
GB (1) GB2014155B (fr)
IT (1) IT1114497B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126858A (en) * 1977-03-03 1978-11-21 Raytheon Company Display range marker
US4125834A (en) * 1977-03-14 1978-11-14 Raytheon Company Display range marker processor
EP0456088B1 (fr) * 1990-05-09 1996-08-21 F. Hoffmann-La Roche Ag Réactif stabilisé pour le dosage de l'acide urique
DE69220871T2 (de) 1991-10-03 1997-11-20 Bayer Ag Vorrichtung und Verfahren zur Auftrennung und Analyse von Vollblut
US5353449A (en) * 1993-07-16 1994-10-11 Tinkle Magic, Inc. Toilet training method
CN108107199B (zh) * 2017-12-21 2019-02-12 广州市进德生物科技有限公司 一种酶化学发光法测定尿酸的检测试剂盒

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1589037A (fr) * 1967-10-14 1970-03-16
US3616231A (en) * 1968-11-14 1971-10-26 Boehringer Mannheim Gmbh Process for the production of uricase
FR2261528A1 (fr) * 1974-02-15 1975-09-12 Hoffmann La Roche
US4119405A (en) * 1978-02-13 1978-10-10 Miles Laboratories, Inc. Test means and method for interference resistant determination of oxidizing substances

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2149675C3 (de) * 1970-10-05 1973-11-29 Dr. Heinz Haury Chemische Fabrik, 8000 Muenchen Verfahren zur quantitativen Be Stimmung von Harnsaure
JPS5033795B1 (fr) * 1970-11-25 1975-11-04
US3928137A (en) * 1971-10-20 1975-12-23 Mallinckrodt Inc Reagent formulation for uric acid assay
DE2237940C3 (de) * 1972-08-02 1980-12-11 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur quantitativen Bestimmung von Harnsäure
JPS49131197A (fr) * 1973-04-19 1974-12-16
US4062731A (en) * 1976-07-21 1977-12-13 Eastman Kodak Company Production of uricase from micrococcus luteus

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1589037A (fr) * 1967-10-14 1970-03-16
US3616231A (en) * 1968-11-14 1971-10-26 Boehringer Mannheim Gmbh Process for the production of uricase
FR2261528A1 (fr) * 1974-02-15 1975-09-12 Hoffmann La Roche
US4119405A (en) * 1978-02-13 1978-10-10 Miles Laboratories, Inc. Test means and method for interference resistant determination of oxidizing substances

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EXBK/69 *
EXBK/71 *

Also Published As

Publication number Publication date
DE2855433A1 (de) 1979-08-16
IT1114497B (it) 1986-01-27
US4230798A (en) 1980-10-28
JPS5841835B2 (ja) 1983-09-14
GB2014155A (en) 1979-08-22
AU514609B2 (en) 1981-02-19
AU4415479A (en) 1979-08-23
CA1093440A (fr) 1981-01-13
FR2417105B1 (fr) 1983-07-08
GB2014155B (en) 1982-06-09
JPS584916B2 (ja) 1983-01-28
JPS589697A (ja) 1983-01-20
JPS6180B2 (fr) 1986-01-06
DE2855433C2 (de) 1986-06-26
IT7947953A0 (it) 1979-02-09
JPS54121199A (en) 1979-09-20
JPS585190A (ja) 1983-01-12

Similar Documents

Publication Publication Date Title
FR2442272A1 (fr) Indicateur enzymatique, methode et dispositif analytiques pour la recherche de glucose dans des liquides
CA2141765A1 (fr) Emulsion contenant de l'acide ascorbique stabilise, procede de traitement cosmetique la mettant en oeuvre, ses utilisations
FR2449727A1 (fr) Composition analytique a base de glucose-oxydase, dispositif et methode de dosage du glucose dans un echantillon de liquide corporel
DK249085D0 (da) Testmateriale til bestemmelse af naervaerelsen af ethanol i en vandig proeve, dets fremstilling og anvendelse
FR2443062A1 (fr) Detection rapide des bacteries
ATE19895T1 (de) Stabilisierung von oxidase.
Vitai et al. Reference ranges of normal blood catalase activity and levels in familial hypocatalasemia in Hungary
FR2417105A1 (fr) Composition a base d'uricase et son application au dosage de l'acide urique
TNSN92015A1 (fr) Composition pharmaceutique
FR2372426A1 (fr)
White et al. Structure-function relations in platelet-thrombin reactions. Inhibition of platelet-thrombin interactions by lysine modification.
de Verneuil et al. Hereditary hepatic porphyria with delta aminolevulinate dehydrase deficiency: immunologic characterization of the non-catalytic enzyme
TNSN97184A1 (fr) Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
FR2454097A1 (fr) Composition renfermant l'ion ferrocyanure et ses applications au dosage d'acide urique dans un echantillon liquide
ATE178074T1 (de) Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes
Harvey et al. Fluorometric assay of protein in native human bile
FR2506766A1 (fr) Sel de l-lysine ou de dl-lysine de l'acide 5-(p-chlorobenzoyl)-1,4-dimethylpyrrole-2-acetique, son procede de preparation et composition analgesique le contenant
Qujeq et al. Effects of sodium fluoride on total serum protein levels and transaminase activity in rats
Sihotang et al. Studies of a possible relationship of brain proteins to changes in behavioral sensitivity to DFP
FR2434393A1 (fr) Dispositif et methode de determination de la teneur en uree de liquides
Togari et al. Highly sensitive assay for alkaline and acid phosphatase activities by high-performance liquid chromatography with electrochemical detection
Tenovuo et al. Formation of dityrosine by human salivary lactoperoxidase in vitro
Yaegaki et al. Influence of aging on DNase activity in human parotid saliva
BE904146A (fr) Compositions pharmaceutiques a base de 3-aminopropoxyindoles.
Strupler Extent of Monochloramine Interference in the DPD Colorimetric Method for Free Chlorine in Water

Legal Events

Date Code Title Description
ST Notification of lapse